A federal judge in California sided with Lance Armstrong and the publishers of his autobiographies on Tuesday, rejecting claims in a lawsuit that lies about not using performance-enhancing drugs amounted to fraud and false advertising.
Already an outcast in cycling after a massive doping report, Lance Armstrong absorbed hits much closer to home Wednesday: to his wallet and his heart. Armstrong was dumped by Nike, Anheuser-Busch and other sponsors, and he gave up the top spot at Livestrong, his beloved cancer-fighting charity, a week after an anti-doping agency released evidence of drug use by the seven-time Tour de France winner.
The U.S. Anti-Doping Agency says 11 of Lance Armstrong's former teammates testified against him in its investigation of the cyclist, revealing "the most sophisticated, professionalized and successful doping program that sport has ever seen."
The head of cycling's governing body says the wait to receive the U.S. evidence in Lance Armstrong's doping case is a "cause for concern." The UCI complained Thursday about what it sees as a delay in receiving the U.S. Anti-Doping Agency's files that led the agency to wipe out years of Armstrong's results, including his seven Tour de France titles.
The head of the U.S. Anti-Doping Agency tightened security at his organization after receiving several death threats during his investigation of Lance Armstrong.